Antiprotozoal

3 marketed 1 in Phase 3

This page covers all Antiprotozoal drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Ornithine decarboxylase (ODC), Muscarinic acetylcholine receptor M4.

Targets

Ornithine decarboxylase (ODC) · Muscarinic acetylcholine receptor M4

Marketed (3)

Vaniqa · Other
Eflornithine inhibits ornithine decarboxylase, reducing polyamine synthesis and affecting cancer cell growth and metabolism.
Pentam · Fresenius Kabi · Metabolic
Pentamidine works by interfering with the reproduction of certain parasites, such as Pneumocystis jiroveci.
Ameparomo · Infectious Disease

Phase 3 pipeline (1)

Propamidine 0.1% · SIFI SpA · Infectious Diseases
Propamidine is an antiprotozoal agent that works by inhibiting the growth of protozoa.